Bone status of 5-8 year olds, treated with dexamethasone for chronic lung disease of prematurity
- Judith A Eelloo (judith.eelloo{at}cmmc.nhs.uk)
- Steven A Roberts (steve.roberts{at}manchester.ac.uk)
- Anthony J. B. Emmerson (anthony.emmerson{at}cmmc.nhs.uk)
- Kathryn A Ward (kate.ward{at}manchester.ac.uk)
- Judith E Adams (judith.adams{at}manchester.ac.uk)
Abstract
Total body bone mineral content and bone mineral apparent density of the lumbar spine were lower in children whose chronic lung disease was treated with dexamethasone (Dx) in the neonatal period, compared to pre-term controls. Therefore, Dx treatment in the neonatal period appears to cause impairment of mineralisation, which persists into childhood.









